Phibro Animal Health Corporation (PAHC)

Market Cap	911.33M
Revenue (ttm)	1.11B
Net Income (ttm)	19.32M
Shares Out	40.50M
EPS (ttm)	0.48
PE Ratio	47.18
Forward PE	11.58
Dividend	$0.48 (2.13%)
Ex-Dividend Date	Mar 5, 2025

Volume	289,706
Open	23.20
Previous Close	22.97
Day's Range	22.31 - 23.20
52-Week Range	11.99 - 26.55
Beta	0.52
Analysts	Sell
Price Target	21.00 (-6.67%)
Earnings Date	Feb 5, 2025

About PAHC

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Apr 11, 2014
• Employees: 1,940
• Stock Exchange: NASDAQ
• Ticker Symbol: PAHC
• Website: https://www.pahc.com

Financial Performance

In 2024, Phibro Animal Health's revenue was $1.02 billion, an increase of 4.07% compared to the previous year's $977.89 million. Earnings were $2.42 million, a decrease of -92.59%.

Analyst Forecast

According to 4 analysts, the average rating for PAHC stock is "Sell." The 12-month stock price forecast is $21.0, which is a decrease of -6.67% from the latest price.

Price Target

$21.0

(-6.67% downside)

Analyst Consensus: Sell